Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Tolerability of TENS in Endometriosis-related Pain

NCT: NCT07393295 · RECRUITING

NCT IDNCT07393295
StatusRECRUITING
Start Date2026-03-15
Completion2027-12-31

Brief Summary

ELECTRE is a single-center, randomized, prospective, longitudinal, controlled, two-arm, single-blind study lasting 4 weeks (P1 investigation phase) after a 4-week run-in period. The study is followed by a 4-week extension phase (P2) in which all participants will be treated with active TENS. Randomization will be balanced according to a 1:1 ratio.

Frequently Asked Questions

What is Efficacy and Tolerability of TENS in Endometriosis-related Pain?

Efficacy and Tolerability of TENS in Endometriosis-related Pain is a clinical trial registered under NCT07393295. Current status: RECRUITING.

What is the status of NCT07393295?

The current status of NCT07393295 (Efficacy and Tolerability of TENS in Endometriosis-related Pain) is: RECRUITING.

When did Efficacy and Tolerability of TENS in Endometriosis-related Pain start?

Efficacy and Tolerability of TENS in Endometriosis-related Pain started on 2026-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.